337
Participants
Start Date
February 29, 2008
Primary Completion Date
February 28, 2011
Study Completion Date
February 28, 2011
larotaxel (XRP9881)
administered on day 1 as a 1-hour infusion
gemcitabine
administered on day 1, 8 and 15 as a 30-minute infusion
cisplatin
1 hour infusion administered on day 1, 30 minutes after the other treatment
Sanofi-Aventis Investigational Site Number 056001, Brussels
Sanofi-Aventis Investigational Site Number 056002, Brussels
Sanofi-Aventis Investigational Site Number 056004, Ottignies
Sanofi-Aventis Investigational Site Number 032005, Rosario
Sanofi-Aventis Investigational Site Number 036004, St Leonards
Sanofi-Aventis Investigational Site Number 056003, Wilrijk
Sanofi-Aventis Investigational Site Number 032001, Santa Fe
Sanofi-Aventis Investigational Site Number 710007, Durban
Sanofi-Aventis Investigational Site Number 710009, Durban
Sanofi-Aventis Investigational Site Number 036002, Adelaide
Sanofi-Aventis Investigational Site Number 036003, Bedford Park
Sanofi-Aventis Investigational Site Number 032004, Mendoza
Sanofi-Aventis Investigational Site Number 056006, Yvoir
Sanofi-Aventis Investigational Site Number 710006, Port Elizabeth
Sanofi-Aventis Investigational Site Number 710003, Cape Town
Sanofi-Aventis Investigational Site Number 710001, Cape Town
Sanofi-Aventis Investigational Site Number 056005, Aalst
Sanofi-Aventis Investigational Site Number 710008, Bloemfontein
Sanofi-Aventis Investigational Site Number 840013, New York
Sanofi-Aventis Investigational Site Number 840050, New York
Sanofi-Aventis Investigational Site Number 840044, Lake Success
Sanofi-Aventis Investigational Site Number 840015, Syracuse
Sanofi-Aventis Investigational Site Number 840056, Rochester
Sanofi-Aventis Investigational Site Number 724011, Santiago de Compostela
Sanofi-Aventis Investigational Site Number 840020, Bethlehem
Sanofi-Aventis Investigational Site Number 840065, Dunmore
Sanofi-Aventis Investigational Site Number 840034, Washington D.C.
Sanofi-Aventis Investigational Site Number 840021, Washington D.C.
Sanofi-Aventis Investigational Site Number 484003, Aguascalientes
Sanofi-Aventis Investigational Site Number 840045, Baltimore
Sanofi-Aventis Investigational Site Number 792006, Istanbul
Sanofi-Aventis Investigational Site Number 380006, Pavia
Sanofi-Aventis Investigational Site Number 840041, Chapel Hill
Sanofi-Aventis Investigational Site Number 724003, Madrid
Sanofi-Aventis Investigational Site Number 840007, Charlotte
Sanofi-Aventis Investigational Site Number 840052, Charleston
Sanofi-Aventis Investigational Site Number 840060, Athens
Sanofi-Aventis Investigational Site Number 484007, Chihuahua City
Sanofi-Aventis Investigational Site Number 724009, Pamplona
Sanofi-Aventis Investigational Site Number 376005, Haifa
Sanofi-Aventis Investigational Site Number 484005, Chihuahua City
Sanofi-Aventis Investigational Site Number 840049, Jacksonville
Sanofi-Aventis Investigational Site Number 724010, Oviedo
Sanofi-Aventis Investigational Site Number 250003, Bordeaux
Sanofi-Aventis Investigational Site Number 840048, Boynton Beach
Sanofi-Aventis Investigational Site Number 840001, Boca Raton
Sanofi-Aventis Investigational Site Number 840061, Lakeland
Sanofi-Aventis Investigational Site Number 792001, Istanbul
Sanofi-Aventis Investigational Site Number 840002, Knoxville
Sanofi-Aventis Investigational Site Number 840057, Paducah
Sanofi-Aventis Investigational Site Number 840019, Sylvania
Sanofi-Aventis Investigational Site Number 376004, Kfar Saba
Sanofi-Aventis Investigational Site Number 250008, Saint-Herblain
Sanofi-Aventis Investigational Site Number 840039, Goshen
Sanofi-Aventis Investigational Site Number 380005, Meldola
Sanofi-Aventis Investigational Site Number 840006, Detroit
Sanofi-Aventis Investigational Site Number 840026, Lansing
Sanofi-Aventis Investigational Site Number 376003, Petah Tikva
Sanofi-Aventis Investigational Site Number 840047, Saint Joseph
Sanofi-Aventis Investigational Site Number 724012, Zaragoza
Sanofi-Aventis Investigational Site Number 376007, Tel Litwinsky
Sanofi-Aventis Investigational Site Number 840038, Milwaukee
Sanofi-Aventis Investigational Site Number 840011, Madison
Sanofi-Aventis Investigational Site Number 840025, Marshfield
Sanofi-Aventis Investigational Site Number 840024, Maywood
Sanofi-Aventis Investigational Site Number 792004, Ankara
Sanofi-Aventis Investigational Site Number 840062, Peoria
Sanofi-Aventis Investigational Site Number 376002, Tel Aviv
Sanofi-Aventis Investigational Site Number 484004, Monterrey
Sanofi-Aventis Investigational Site Number 250012, Perpignan
Sanofi-Aventis Investigational Site Number 250009, Strasbourg
Sanofi-Aventis Investigational Site Number 250004, Lyon
Sanofi-Aventis Investigational Site Number 380004, Bari
Sanofi-Aventis Investigational Site Number 376001, Tzrifin
Sanofi-Aventis Investigational Site Number 250011, Le Mans
Sanofi-Aventis Investigational Site Number 380003, Lecce
Sanofi-Aventis Investigational Site Number 840064, Temple
Sanofi-Aventis Investigational Site Number 840008, Houston
Sanofi-Aventis Investigational Site Number 840018, Houston
Sanofi-Aventis Investigational Site Number 840010, The Woodlands
Sanofi-Aventis Investigational Site Number 840016, San Antonio
Sanofi-Aventis Investigational Site Number 840017, Lubbock
Sanofi-Aventis Investigational Site Number 840031, Denver
Sanofi-Aventis Investigational Site Number 250005, Hyères
Sanofi-Aventis Investigational Site Number 840030, Boise
Sanofi-Aventis Investigational Site Number 250006, Avignon
Sanofi-Aventis Investigational Site Number 250007, Poitiers
Sanofi-Aventis Investigational Site Number 840046, Los Angeles
Sanofi-Aventis Investigational Site Number 840012, Burbank
Sanofi-Aventis Investigational Site Number 840029, La Jolla
Sanofi-Aventis Investigational Site Number 840033, San Diego
Sanofi-Aventis Investigational Site Number 250001, Suresnes
Sanofi-Aventis Investigational Site Number 840005, San Bernardino
Sanofi-Aventis Investigational Site Number 840035, Berkeley
Sanofi-Aventis Investigational Site Number 840003, Sacramento
Sanofi-Aventis Investigational Site Number 840036, Seattle
Sanofi-Aventis Investigational Site Number 840068, Anchorage
Sanofi-Aventis Investigational Site Number 643006, Moscow
Sanofi-Aventis Investigational Site Number 356001, New Delhi
Sanofi-Aventis Investigational Site Number 643008, Moscow
Sanofi-Aventis Investigational Site Number 643004, Moscow
Sanofi-Aventis Investigational Site Number 643005, Moscow
Sanofi-Aventis Investigational Site Number 643002, Saint Petersburg
Sanofi-Aventis Investigational Site Number 643003, Saint Petersburg
Sanofi-Aventis Investigational Site Number 643007, Saint Petersburg
Sanofi-Aventis Investigational Site Number 643011, Saint Petersburg
Sanofi-Aventis Investigational Site Number 643001, Obninsk
Sanofi-Aventis Investigational Site Number 643010, Kursk
Sanofi-Aventis Investigational Site Number 643009, Chelyabinsk
Sanofi-Aventis Investigational Site Number 356005, Visakhapatnam
Sanofi-Aventis Investigational Site Number 356003, Bangalore
Sanofi-Aventis Investigational Site Number 356002, Vellore
Sanofi-Aventis Investigational Site Number 356007, Kolkata
Sanofi-Aventis Investigational Site Number 152001, Santiago
Sanofi-Aventis Investigational Site Number 840032, Stamford
Sanofi-Aventis Investigational Site Number 840054, Kansas City
Sanofi-Aventis Investigational Site Number 840004, Metarie
Sanofi-Aventis Investigational Site Number 840009, Hackensack
Sanofi-Aventis Investigational Site Number 840058, Woonsocket
Sanofi-Aventis Investigational Site Number 032002, Buenos Aires
Sanofi-Aventis Investigational Site Number 032003, Ciudad de Buenos Aires
Sanofi-Aventis Investigational Site Number 076006, Barretos
Sanofi-Aventis Investigational Site Number 076004, Florianópolis
Sanofi-Aventis Investigational Site Number 076001, Porto Alegre
Sanofi-Aventis Investigational Site Number 076003, Porto Alegre
Sanofi-Aventis Investigational Site Number 076002, Rio de Janeiro
Sanofi-Aventis Investigational Site Number 076007, São Paulo
Sanofi-Aventis Investigational Site Number 076005, São Paulo
Sanofi-Aventis Investigational Site Number 124007, Edmonton
Sanofi-Aventis Investigational Site Number 124001, London
Sanofi-Aventis Investigational Site Number 124006, Montreal
Sanofi-Aventis Investigational Site Number 124003, Québec
Sanofi-Aventis Investigational Site Number 124002, Weston
Sanofi-Aventis Investigational Site Number 356004, New Delhi
Sanofi-Aventis Investigational Site Number 380002, Perugia
Sanofi-Aventis Investigational Site Number 380001, Roma
Sanofi-Aventis Investigational Site Number 380008, Viterbo
Sanofi-Aventis Investigational Site Number 528005, Amsterdam
Sanofi-Aventis Investigational Site Number 528002, Arnhem
Sanofi-Aventis Investigational Site Number 528006, Hoofddorp
Sanofi-Aventis Investigational Site Number 528003, Maastricht
Sanofi-Aventis Investigational Site Number 528004, Nijmegen
Sanofi-Aventis Investigational Site Number 528001, Sittard-Geleen
Sanofi-Aventis Investigational Site Number 528007, Zwolle
Sanofi-Aventis Investigational Site Number 616002, Poznan
Sanofi-Aventis Investigational Site Number 616004, Rybnik
Sanofi-Aventis Investigational Site Number 616001, Warsaw
Sanofi-Aventis Investigational Site Number 616005, Wroclaw
Sanofi-Aventis Investigational Site Number 710005, Pretoria
Sanofi-Aventis Investigational Site Number 724006, Badalona
Sanofi-Aventis Investigational Site Number 724001, Barcelona
Sanofi-Aventis Investigational Site Number 724004, Barcelona
Sanofi-Aventis Investigational Site Number 724008, Barcelona
Sanofi-Aventis Investigational Site Number 724002, Barcelona
Sanofi-Aventis Investigational Site Number 724013, Palma de Mallorca
Sanofi-Aventis Investigational Site Number 724007, Palma de Mallorca
Sanofi-Aventis Investigational Site Number 752001, Umeå
Sanofi-Aventis Investigational Site Number 752002, Uppsala
Sanofi-Aventis Investigational Site Number 792002, Ankara
Sanofi-Aventis Investigational Site Number 792003, Ankara
Lead Sponsor
Sanofi
INDUSTRY